Predicting the unpredictable: Is it possible clinically to separate H1N1 from non-H1N1 community-acquired pneumonia?

Thorax

Volumn 66, Issue 3, 2011, Pages 187-188

  Sehgal, Nita ^a   Woodhead, Mark ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; COMMUNITY ACQUIRED PNEUMONIA; CYSTIC FIBROSIS; EDITORIAL; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION CONTROL; INFLUENZA B; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; NOSE SMEAR; PATIENT CARE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 79951897568     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.157404     Document Type: Editorial

References (18)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15.
2. Perez-Padilla R, Rosa-Zamborini D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-9.
3. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-19.
4. World Health Organization. Pandemic (H1N1) 2009. 2009. http://www.who.int/csr/don/2010-06-11/en/index.html.
5. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, AprileJune 2009. N Engl J Med 2009;361:1935-44.
6. Ramsey C, Kumar A. H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. Curr Opin Crit Care 2011;17:64-71.
7. Riquelme R, Torres A. Influenza pneumonia: a comparison between seasonal influenza virus and H1N1 pandemic. Eur Respir J Published Online First: 25 Nov 2010. doi:10.1183/09031936.00125910.
8. Falagas ME, Koletsi PK, Baskouta E, et al. Pandemic A (H1N1) 2009 influenza: review of the Southern Hemisphere experience. Epidemiol Infect 2011;139:27-40.
9. McLean E, Pebody R. HPA Weekly National Influenza Report: Summary of UK Surveillance of Influenza and Other Respiratory Illness. 12.0.11.
10. Jefferson T, Jones MA, Di Pietrantonj C, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2006(3): CD001265.
11. National Institute for Health and Clinical Excellence (NICE). Amantadine, Oseltamivir, Zanamivir for the Treatment of Influenza: Review of NICE Technology Appraisal Guidance 58. London: NICE, 2009.
12. Health Protection Agency. Pharmacological Treatment and Prophylaxis of Influenza. Health Protection Agency, 2011. Version 1.7 2011.
13. Bewick T, Myles P, Greenwood S, et al. Clinical and laboratory features distinguishing pandemic H1N1influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax 2011;66:247-52.
14. Helferty M, Vachon J, Tarasuk J, et al. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 2010;182:1981-7.
15. Blyth C, Iredall J, Dwyer D. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;361:2493.
16. Mulrennan S, Tempone SS, Wai Ling IT, et al. Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. PLoS One 2010;5:e12849.
17. Colombo C, Battezzati PM, Lucidi V, et al. Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study. Thorax 2011;66:260-1.
18. Nash EF, Whitmill R, Barker B, et al. Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis. Thorax 2011;66:259.